Objective Human embryonic stem cell (hESC) research holds promise for regenerative therapies, offers a tool for drug discovery and toxicity tests, for studying human development, disease physiology and gene control. hESC lines are derived in an increasing number of laboratories accompanied by a widening scope of usage and application. This trend has not diminished since human induced pluripotent stem cells (hiPSC) became available as research and use of hESC and hiPSC rapidly co-develop. The advancing scope of the field, the increasing count of researchers, laboratories and institutions working with pluripotent stem cells (hPSC) and the ever growing number of hESC and hiPSC lines poses novel challenges, while further justifying the recognized need for a registry of hESC. This need has been addressed by establishing the European hESC registry (EU-hESCreg). The proposed project aims at sustaining and improving operability of EU-hESCreg, and to expand its content and usability in order to respond to the existing and anticipated challenges in the field. The European human pluripotent stem cell registry (EU-hPSCreg) will adapt its registration content and requirements to accommodate hESC and hiPSC. The inclusion of these most relevant pluripotent stem cells (hPSC) will broaden comparability and standardization of cell lines, advance knowledge dissemination and hence reduce the need for generating new hESC lines. The objective of the EU-hPSCreg is to promote access to hPSC lines and to provide transparency about their characteristics, to contribute to the harmonization of hPSC usage and develop it into an international hub. The project will (i) implement transparent criteria for registration, qualification and validation of hPSC, (ii) establish efficient means and tools for internal and external communication and dissemination of information , (iii) provide a reliable technical and regulatory basis for operation and (iv) establish efficient and strategic management. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverymedical and health sciencesmedical biotechnologycells technologiesstem cellsmedical and health sciencesbasic medicinephysiology Programme(s) FP7-HEALTH - Specific Programme "Cooperation": Health Topic(s) HEALTH - SP3 Food, chemical products and health Call for proposal FP7-Adhoc-2007-13 See other projects for this call Funding Scheme CSA-SA - Support actions Coordinator CHARITE - UNIVERSITAETSMEDIZIN BERLIN EU contribution € 310 301,84 Address Chariteplatz 1 10117 Berlin Germany See on map Region Berlin Berlin Berlin Activity type Higher or Secondary Education Establishments Administrative Contact Eveline Fräßdorf (Ms.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Participants (3) Sort alphabetically Sort by EU Contribution Expand all Collapse all FUNDACIO PRIVADA CENTRE DE MEDICINA REGENERATIVA DE BARCELONA Spain EU contribution € 93 933,16 Address Dr. Aiguader 88 08003 BARCELONA See on map Activity type Research Organisations Administrative Contact Miguel Gomez Clares (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data HEALTH PROTECTION AGENCY HPA Participation ended United Kingdom EU contribution No data Address BUCKINGHAM PALACE ROAD 151 SW1W 9SZ London See on map Activity type Research Organisations Administrative Contact Amanda King (Mrs.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Department of Health United Kingdom EU contribution € 95 765,00 Address Quarry House, Quarry Hill LS2 7UE Leeds See on map Region Yorkshire and the Humber West Yorkshire Leeds Activity type Research Organisations Administrative Contact Amanda King (Mrs.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data
